ANI Pharmaceuticals, Inc. (BST:BSFA)
Germany flag Germany · Delayed Price · Currency is EUR
54.50
+1.50 (2.83%)
At close: Jul 3, 2025

ANI Pharmaceuticals Company Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.

It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products.

It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians.

ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

ANI Pharmaceuticals, Inc.
Country United States
Founded 2001
Industry Pharmaceutical Preparations
Employees 897
CEO Nikhil Lalwani

Contact Details

Address:
210 Main Street West
Baudette, Delaware 56623
United States
Phone 218 634 3500
Website anipharmaceuticals.com

Stock Details

Ticker Symbol BSFA
Exchange Stuttgart Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
SIC Code 2834

Key Executives

Name Position
Nikhil Lalwani Chief Executive Officer
Stephen Carey Chief Financial Officer